Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;458(5):561-9.
doi: 10.1007/s00428-011-1042-9. Epub 2011 Jan 29.

Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas

Xiao-Jie Ding  1 , Min-Xia Liu, Lei Ao, Yi-Rong Liang, Yi Cao
Affiliations

Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas

Xiao-Jie Ding et al. Virchows Arch. 2011 May.

Abstract

Chromosomal aberrations in non-small-cell lung carcinomas (NSCLCs) are common events. In our study, the lung cancer cell lines (NCI-H446 and SPC-A-1) displayed numerous numerical and structural alterations in their chromosomes by G-banded karyotypic analysis, and abnormalities of chromosome 12 by fluorescence in situ hybridization. Sequentially, we used 14 microsatellite markers within 12q to analyze loss of heterozygosity (LOH) in lung cancer cell lines and NSCLCs. Possible LOH on 12q were statistically inferred to occur in five lung cell lines. Importantly, 17 out of 25 NSCLCs (68%) showed LOH at chromosome 12q. Frequencies of LOH for individual markers ranged from 18% to 44%. Several deletions which were marked with D12S1301, D12S2196, D12S398, D12S90, D12S1056, D12S1713, D12S375, D12S1040, D12S326, and D12S106 were newly detected. Allelic loss on 12q15-q21 detected with D12S1040 occurred at the later stages of NSCLC progression (p < 0.05, Fisher's exact test). LOH on 12q marked with D12S2196, D12S398, D12S326, and D12S106 were frequently found in NSCLCs from the patients without smoking history (p < 0.05, Fisher's exact test). These findings indicated that allelic loss on 12q is commonly involved in NSCLCs, and new tumor suppressor genes may occur within 12q.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lancet. 1971 Oct 30;2(7731):971-2 - PubMed
    1. Cancer Res. 1998 Aug 15;58(16):3700-5 - PubMed
    1. Lung Cancer. 2003 Jan;39(1):23-9 - PubMed
    1. Lab Invest. 2005 Sep;85(9):1076-85 - PubMed
    1. Int J Oncol. 2003 Nov;23(5):1357-63 - PubMed

Publication types

LinkOut - more resources